{
    "clinical_study": {
        "@rank": "58819", 
        "arm_group": [
            {
                "arm_group_label": "lidocaine", 
                "arm_group_type": "Experimental", 
                "description": "The treatment group will receive a 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point. Three to five points injection."
            }, 
            {
                "arm_group_label": "Sham needling", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham needle is a modification of the acupuncture needle. The tips of needles are blunted and applied to the skin over the trigger point without penetrating skin."
            }
        ], 
        "brief_summary": {
            "textblock": "To determine the efficacy of lidocaine injection of trigger points versus placebo in\n      patients with subacute whiplash associated disorder following injury."
        }, 
        "brief_title": "Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Whiplash Injuries,", 
            "Neck Pain,"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neck Pain", 
                "Whiplash Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine\n      injection of trigger points versus placebo in patients with subacute whiplash associated\n      disorder following injury.  Outcomes include pain, objective assessment, self-report\n      function recovery, impact on work performance and globe perceived effects which will be\n      assessed 5 minutes, 2 and 6 weeks following injection."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  fulfill the Grade II Quebec Task Force classification of WAD,\n\n          -  with identifiable myofascial trigger points ( which occur with or without a taut\n             band),\n\n          -  reproduction of recognizable pain with sustained pressure ( up to 10 seconds) on\n             trigger points\n\n          -  aged 18 to 70\n\n          -  a good understanding of informed consent and willing to attend this trial.\n\n        Exclusion Criteria:\n\n          -  have serious injury such as fracture and internal bleeding\n\n          -  suspicion of upper cervical instability or neurological deficits\n\n          -  clinical evidence of radiculopathy\n\n          -  a history of active cancer, central nerve disorder, blood clotting disorders, needle\n             phobia\n\n          -  anticoagulant medication user\n\n          -  previous experience with any type of needling for myofascial pain"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02060734", 
            "org_study_id": "HHSCTRIGGERINJ1402"
        }, 
        "intervention": [
            {
                "arm_group_label": "lidocaine", 
                "description": "Lidocaine injection 3-5 points in experimental group( using 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point).", 
                "intervention_name": "Lidocaine", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Sham needling", 
                "description": "Blunted acupuncture needle ( sham needle ) applies to trigger point without penetrating skin", 
                "intervention_name": "Sham needling", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Whiplash,", 
            "injection,", 
            "lidocaine,", 
            "sham needling"
        ], 
        "lastchanged_date": "February 10, 2014", 
        "location": {
            "contact": {
                "email": "dharvey@hhsc.ca", 
                "last_name": "David Harvey"
            }, 
            "facility": {
                "address": {
                    "city": "Hamilton", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "L8V 1C3"
                }, 
                "name": "HHS (Juravinski Hospital Site)"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated disorder-a Randomized Controlled Trial", 
        "overall_contact": {
            "email": "dharvey@hhsc.ca", 
            "last_name": "David Harvey, MD", 
            "phone": "9055748515"
        }, 
        "overall_official": {
            "affiliation": "McMaster University", 
            "last_name": "Joy MacDermid, Ph.D.", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "10 cm Visual Analog Scale", 
            "measure": "pain", 
            "safety_issue": "No", 
            "time_frame": "2 weeks following injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02060734"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hamilton Health Sciences Corporation", 
            "investigator_full_name": "Maggie Qiyun Shi", 
            "investigator_title": "Graduate student, Western University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "cervical range of motion", 
                "safety_issue": "No", 
                "time_frame": "Immediately, 2 and 6 weeks after injection"
            }, 
            {
                "measure": "self-report neck disability", 
                "safety_issue": "No", 
                "time_frame": "Immediately, 2 and 6 weeks after injection"
            }, 
            {
                "description": "The Short Form-12", 
                "measure": "globe perceived effects", 
                "safety_issue": "No", 
                "time_frame": "Immediately, 2 and 6 weeks after injection"
            }, 
            {
                "description": "questionnaire", 
                "measure": "work performance", 
                "safety_issue": "No", 
                "time_frame": "Immediately, 2 and 6 weeks after injection"
            }, 
            {
                "description": "10 cm Visual Analog Scale", 
                "measure": "pain", 
                "safety_issue": "No", 
                "time_frame": "5 minutes following injection"
            }, 
            {
                "description": "10 cm Visual Analog Scale", 
                "measure": "pain", 
                "safety_issue": "No", 
                "time_frame": "6 weeks following injection"
            }
        ], 
        "source": "Hamilton Health Sciences Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hamilton Health Sciences Corporation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}